HistoSonics specializes in developing non-invasive medical devices, interventional radiology, and surgical robotics.
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 13, 2022 | Convertable Note | $85M | 5 |
![]() |
— | Detail |
Dec 13, 2022 | Debt Financing | $15M | 1 |
![]() |
— | Detail |
Jun 8, 2020 | Series C | $40M | 6 |
![]() |
— | Detail |
Apr 8, 2019 | Series C | $54.70M | 5 |
![]() ![]() ![]() |
— | Detail |
Jul 13, 2018 | Series Unknown | $4.82M | — | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 17, 2021
![]() |
Series D | $450M | Aerospace | — |
Dec 31, 2019
![]() |
Series A | $7M | Advanced Materials | — |
Jul 15, 2019
![]() |
Pre-seed | — | Blockchain | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Convertable Note |
![]() |
Yes | Debt Financing |
![]() |
Yes | Series C |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Convertable Note |
![]() |
— | Series C |
![]() |
— | Series C |
![]() |
— | Series B |